Cervical Cancer Clinical Trials in New Brunswick, New Jersey

4 studies are recruiting for cervical cancer in New Brunswick, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

   This is a phase I clinical trial to determine the maximum tolerated dose (MTD) of KK-LC-1 TCR-T cells for the treatment of metastatic cancers that express KK-LC-1. Participants will receive a conditioning regimen, KK-LC-1 TCR-T cells, and aldesleukin. The safety profile and clinical response to tre…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Rutgers Cancer Institute, New Brunswick, New Jersey

   Locations

   2 in total

   Run by

   Christian Hinrichs

   See if you can join NCT05483491 on ClinicalTrials.gov

2. E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

   The goal of this study is to determine the feasibility of administration of a single dose of E7 TCR-T cells as induction therapy prior to definitive treatment (chemoradiation or surgery) of locoregionally advanced HPV-associated cancers. The intent of E7 TCR-T cell treatment is to shrink or elimina…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Rutgers Cancer Institute, New Brunswick, New Jersey

   Locations

   2 in total

   Run by

   Christian Hinrichs

   See if you can join NCT05639972 on ClinicalTrials.gov

3. E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

   This is a phase II clinical trial to assess the clinical activity of immunotherapy with E7 TCR-T cells for metastatic HPV-associated cancers. HPV-associated cancers in include cervical, throat, penile, vulvar, vaginal, anal, and other cancers. Participants will receive a conditioning regimen, E7 TC…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Rutgers Cancer Institute, New Brunswick, New Jersey

   Locations

   3 in total

   Run by

   Christian Hinrichs

   See if you can join NCT05686226 on ClinicalTrials.gov

4. Reducing Urban Cervical Cancer Disparities

   This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women an…

   Stage

   Not phased

   Ages

   18 to 90

   Site

   Rutgers, The State University of New Jersey, New Brunswick, New Jersey

   Locations

   3 in total

   Run by

   Fox Chase Cancer Center

   See if you can join NCT06416150 on ClinicalTrials.gov